Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04532411 · ClinicalTrials.gov registry record
COVID-19 Testing Sample Acquisition Throughput and Efficiency
A clinical trial, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- 28,948
- Enrollment target
NCT04532411: Completed study, sponsored by Massachusetts General Hospital.
NCT04532411 is a clinical trial that has completed, run by Massachusetts General Hospital. The registered enrollment target is 28,948 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04532411 has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- 28,948 participants
- Enrollment target
Study Summary
This QI project seeks to evaluate the relative test sample acquisition throughput, personal protective equipment utilization, and relative operational costs of provider-administered COVID-19 (SARS-CoV-2) nasal samples with and with the use of HEPA-filtered, positive pressure isolation booths.
Primary Outcome
Samples acquired per hour using the Hexapod booth will be assessed as an average over a minimum of 12 weeks of testing compared to baseline throughput before April 16th.
Interventions
- OTHER Personal Protective Testing Booth
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28,948 participants |
| Start Date | 2020-03-01 |
| Est. Completion | 2020-09-30 |
What the finished NCT04532411 record still lists
NCT04532411 is an observational study that tracks outcomes without assigning an intervention. Its 28,948 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Personal Protective Testing Booth is the first listed.
NCT04532411 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04532411 about?
NCT04532411 is a clinical study titled "COVID-19 Testing Sample Acquisition Throughput and Efficiency". This QI project seeks to evaluate the relative test sample acquisition throughput, personal protective equipment utilization, and relative operational costs of provider-administered COVID-19 (SARS-CoV-2) nasal samples with and with the use of HEPA-filtered, positive pressure isolation booths.
What is the current status of trial NCT04532411?
This trial is currently completed. The enrollment target is 28,948 participants. The study started on 2020-03-01. Estimated completion is 2020-09-30.
What interventions are being tested in trial NCT04532411?
The interventions under investigation include: Personal Protective Testing Booth (OTHER).
Who is sponsoring clinical trial NCT04532411?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00684580 · 30,000 participants
Protocol For Collecting Data On Patients With Childhood Cancer
- NCT03053193 · 30,000 participants
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
- NCT03689595 · 30,000 participants
Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
- NCT04834869 · 30,000 participants
COVID-19 Vaccines Safety Tracking (CoVaST)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI